BUCHANG PHARMA: Obtained the drug registration certificate for ibuprofen sustained-release capsules
On October 13th, BUCHANG PHARMA announced that its wholly-owned subsidiary Shandong Danhong Pharmaceutical Co., Ltd. recently received the "Drug Registration Certificate" for ibuprofen sustained-release capsules approved and issued by the National Medical Products Administration. The indications are for the relief of mild to moderate pain such as headaches, joint pain, migraines, toothaches, muscle pain, neuralgia, and dysmenorrhea. It is also used for fever caused by common colds or influenza
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments